Evidence map›Paper›PMID 39575700›Full record

ArticleTissue engineering. Part A2024

Perspectives on Recent Developments and Directions in Tissue Engineering and Regenerative Medicine.

Nasim Annabi, Elizabeth Cosgriff-Hernandez, Anthony S Weiss

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tissue engineering. Part A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nasim AnnabiDepartment of Chemical and Biomolecular Engineering, University of California Los Angeles, Los Angeles, California, USA.
Elizabeth Cosgriff-HernandezDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, Texas, USA.
Anthony S WeissSchool of Life and Environmental Sciences, University of Sydney, Sydney, Australia.

Funding

Engineering highly elastic surgical sealants with hemostatic propertiesR01HL140618 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANNABI, NASIM, KHADEMHOSSEINI, ALI · 2018 to 2021
$2.8M
Engineering a naturally derived and highly adhesive surgical sealantR01EB023052 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANNABI, NASIM, KHADEMHOSSEINI, ALI · 2017 to 2022
$2.4M
Injectable Hydrogel Electrodes to Prevent Ventricular ArrhythmiasR01HL162741 · NHLBI · UNIVERSITY OF TEXAS AT AUSTIN · PI Elizabeth Marie Cosgriff-Hernandez, Mehdi Razavi · 2023 to 2026
$2.4M
Resorbable, Shape Memory Stents to Prevent Vaginal FibrosisR21HD104059 · NICHD · UNIVERSITY OF TEXAS AT AUSTIN · PI COSGRIFF-HERNANDEZ, ELIZABETH MARIE · 2021 to 2022
$444k
In situ BMSC Seeding of 3D Printed Scaffolds Using Cell-releasing HydrogelsR21AR076708 · NIAMS · UNIVERSITY OF TEXAS AT AUSTIN · PI COSGRIFF-HERNANDEZ, ELIZABETH MARIE · 2020 to 2021
$356k
NHLBI NIH HHS R01 HL140618NHLBI NIH HHS R01 HL162741NIAMS NIH HHS R21 AR076708NIBIB NIH HHS R01 EB023052NICHD NIH HHS R21 HD104059
6 · The paper itself

Abstract

This perspective article draws on lessons learned at the 7th TERMIS World Congress held in Seattle, Washington in June 2024. This gathering of prominent researchers and translational scientists in tissue engineering and regenerative medicine (TERM) from around the world provided a forum to consider the impact of tissue engineering and its future directions. New frontiers are considered in the context of global challenges, including clinical translation and recent advances in pediatric tissue engineering, supercritical fluid technology for scaffold fabrication and sterilization, and learning from successful failures in tissue engineering and regenerative medicine. Bench-to-bedside translational strategies, inclusive research strategies, regulatory hurdles, and ethics linked to navigating responsibilities and innovations, are identified as important drivers in the field.

Indexed as

Regenerative MedicineTissue EngineeringAnimalsCongresses as TopicHumansTissue Scaffoldsdirectionsperspectiveregenerative medicinetissue engineering

Identifiers

PMID39575700
PMCPMC12944814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.